S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, Regulatory T cells and immune tolerance, Cell, vol.133, pp.775-787, 2008.

M. Miyara, K. Wing, and S. Sakaguchi, Therapeutic approaches to allergy and autoimmunity based on FOXP3+ regulatory T-cell activation and expansion, The Journal of allergy and clinical immunology, vol.123, pp.756-747, 2009.

S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, and M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25), J Immunol, vol.155, pp.1151-1164, 1995.

S. Hori, T. Nomura, and S. Sakaguchi, Control of regulatory T cell development by the transcription factor FOXP3, Science, vol.299, pp.1057-1061, 2003.

R. Khattri, T. Cox, S. A. Yasayko, and F. Ramsdell, An essential role for Scurfin in CD4+CD25+ T regulatory cells, Nat Immunol, vol.4, pp.337-342, 2003.

J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, FOXP3 programs the development and function of CD4+CD25+ regulatory T cells, Nat Immunol, vol.4, pp.330-336, 2003.

M. Miyara, G. Gorochov, M. Ehrenstein, L. Musset, S. Sakaguchi et al., Human FOXP3+ regulatory T cells in systemic autoimmune diseases, Autoimmun Rev, vol.10, pp.744-755, 2011.

M. Miyara and S. Sakaguchi, Human FOXP3(+)CD4(+) regulatory T cells: their knowns and unknowns, Immunology and cell biology, vol.89, pp.346-351, 2011.

S. Sakaguchi, M. Miyara, C. M. Costantino, and D. A. Hafler, FOXP3+ regulatory T cells in the human immune system, Nature reviews Immunology, vol.10, pp.490-500, 2010.

J. L. Riley, C. H. June, and B. R. Blazar, Human T regulatory cell therapy: take a billion or so and call me in the morning, Immunity, vol.30, pp.656-665, 2009.

C. Baecher-allan, J. A. Brown, G. J. Freeman, and D. A. Hafler, CD4+CD25high regulatory cells in human peripheral blood, J Immunol, vol.167, pp.1245-1253, 2001.

D. Dieckmann, H. Plottner, S. Berchtold, T. Berger, and G. Schuler, Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood, The Journal of experimental medicine, vol.193, pp.1303-1310, 2001.

H. Jonuleit, E. Schmitt, M. Stassen, A. Tuettenberg, J. Knop et al., Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood, The Journal of experimental medicine, vol.193, pp.1285-1294, 2001.

M. K. Levings, R. Sangregorio, and M. G. Roncarolo, Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function, The Journal of experimental medicine, vol.193, pp.1295-1302, 2001.

W. F. Ng, P. J. Duggan, F. Ponchel, G. Matarese, G. Lombardi et al., Human CD4(+) CD25(+) cells: a naturally occurring population of regulatory T cells, Blood, vol.98, pp.2736-2744, 2001.

L. S. Taams, J. Smith, M. H. Rustin, M. Salmon, L. W. Poulter et al.,

, CD25(+) T cells: a highly differentiated and apoptosisprone population, European journal of immunology, 2001.

, www.impactjournals.com/oncotarget, vol.31, pp.1122-1131

J. H. Peters, L. B. Hilbrands, H. J. Koenen, and I. Joosten, Ex vivo generation of human alloantigen-specific regulatory T cells from CD4(pos)CD25(high) T cells for immunotherapy, PloS one, vol.3, p.2233, 2008.

P. Hoffmann, T. J. Boeld, R. Eder, J. Huehn, S. Floess et al., Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation, Eur J Immunol, vol.39, pp.1088-1097, 2009.

S. E. Allan, A. N. Alstad, N. Merindol, N. K. Crellin, M. Amendola et al., Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3, Mol Ther, vol.16, pp.194-202, 2008.

M. Miyara, Y. Yoshioka, A. Kitoh, T. Shima, K. Wing et al., Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FOXP3 transcription factor, Immunity, vol.30, pp.899-911, 2009.

M. Miyara, D. Chader, E. Sage, D. Sugiyama, H. Nishikawa et al., Sialyl Lewis x (CD15s) identifies highly differentiated and most suppressive FOXP3high regulatory T cells in humans, Proc Natl Acad Sci U S A, vol.112, pp.7225-7230, 2015.

M. Battaglia, A. Stabilini, B. Migliavacca, J. Horejs-hoeck, T. Kaupper et al., Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients, J Immunol, vol.177, pp.8338-8347, 2006.

U. Baron, S. Floess, G. Wieczorek, K. Baumann, A. Grutzkau et al., DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells, Eur J Immunol, vol.37, pp.2378-2389, 2007.

S. Floess, J. Freyer, C. Siewert, U. Baron, S. Olek et al., Epigenetic control of the FOXP3 locus in regulatory T cells, PLoS Biol, vol.5, p.38, 2007.

R. Tao, E. F. De-zoeten, E. Ozkaynak, C. Chen, L. Wang et al., Deacetylase inhibition promotes the generation and function of regulatory T cells, Nat Med, vol.13, pp.1299-1307, 2007.

H. J. Koenen, R. L. Smeets, P. M. Vink, E. Van-rijssen, A. M. Boots et al., Human CD25highFOXP3pos regulatory T cells differentiate into IL-17-producing cells, Blood, vol.112, pp.2340-2352, 2008.

J. Van-loosdregt, Y. Vercoulen, T. Guichelaar, Y. Y. Gent, J. M. Beekman et al., Regulation of Treg functionality by acetylation-mediated FOXP3 protein stabilization, Blood, vol.115, pp.965-974, 2010.

P. Hoffmann, R. Eder, T. J. Boeld, K. Doser, B. Piseshka et al., Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion, Blood, vol.108, pp.4260-4267, 2006.

K. L. Hippen, S. C. Merkel, D. K. Schirm, C. M. Sieben, D. Sumstad et al., Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity

, Sci Transl Med, vol.3, pp.83-124, 2011.

M. Miyara, Z. Amoura, C. Parizot, C. Badoual, K. Dorgham et al., The immune paradox of sarcoidosis and regulatory T cells, J Exp Med, vol.203, pp.359-370, 2006.

N. Seddiki, B. Santner-nanan, J. Martinson, J. Zaunders, S. Sasson et al., Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells, The Journal of experimental medicine, vol.203, pp.1693-1700, 2006.

W. Liu, A. L. Putnam, Z. Xu-yu, G. L. Szot, M. R. Lee et al., CD127 expression inversely correlates with FOXP3 and suppressive function of human CD4+ T reg cells, J Exp Med, vol.203, pp.1701-1711, 2006.

A. L. Putnam, T. M. Brusko, M. R. Lee, W. Liu, G. L. Szot et al., Expansion of human regulatory T-cells from patients with type 1 diabetes, Diabetes, vol.58, pp.652-662, 2009.

E. Hennezel, E. Yurchenko, E. Sgouroudis, V. Hay, and C. A. Piccirillo, Single-Cell Analysis of the Human T Regulatory Population Uncovers Functional Heterogeneity and Instability within FOXP3+ Cells, J Immunol, vol.186, pp.6788-6797, 2011.

M. J. Polley, M. L. Phillips, E. Wayner, E. Nudelman, A. K. Singhal et al., CD62 and endothelial cellleukocyte adhesion molecule 1 (ELAM-1) recognize the same carbohydrate ligand, sialyl-Lewis x, Proc Natl Acad Sci U S A, vol.88, pp.6224-6228, 1991.

L. Lu, X. Zhou, J. Wang, S. G. Zheng, and D. A. Horwitz, Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-beta and retinoic acid, PLoS One, vol.5, p.15150, 2010.